Good morning :)
Switch to
Place Order

Solara Active Pharma Sciences Ltd

SOLARA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹4,805 cr, stock is ranked 490
Moderate RiskStock is 2.69x as volatile as Nifty
1,303.6033.85 (-2.53%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹4,805 cr, stock is ranked 490
Moderate RiskStock is 2.69x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
21.70
PB RatioPB Ratio
3.02
Dividend YieldDiv. Yield
0.52%
Sector PESector PE
38.41
Sector PBSector PB
5.12
Sector Div YldSctr Div Yld
0.68%

Forecast & RatingsDetailed Forecast 

80%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

SSL Pharma Sciences is a manufacturer of pharmaceutical preparation

Investor PresentationView older 

Apr 11, 2021

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

20182019202020210.521.401.351.650.000.060.110.22
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 3.04%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Shareholders meeting 
Announced OnOct 19, 2021

Solara Active Pharma Sciences Limited has informed the Exchange regarding - Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that by way of Postal Ballot approval by shareholders, Ms. Vineeta Rai (DIN: 07013113) has been appointed as Independent Director of the Company with effect from October 17, 2021 | Download

Solara Active Pharma Sciences Limited has informed the Exchange regarding - Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that by way of Postal Ballot approval by shareholders, Ms. Vineeta Rai (DIN: 07013113) has been appointed as Independent Director of the Company with effect from October 17, 2021 | Download

Shareholders meeting 
Announced OnOct 19, 2021

Solara Active Pharma Sciences Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results. | Download

Solara Active Pharma Sciences Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results. | Download

Cash Dividend 
Ex. DateAug 18, 2021

Final • Div/Share: ₹ 3

See all events